top of page

Latest News

A Game-Changing drug!

The new Ruxolitinib cream form provides a safer option compared to taking JAK inhibitors by mouth, showing great outcomes in tests with people aged 12 and up who have nonsegmental vitiligo.

AdobeStock_244484697.jpeg

Top Picks

Editor's

bottom of page